Drug-labels.com

Auro-Cefprozil (Auro Pharma, 500 mg, 125 mg, 250 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
500 mg, 125 mg, 250 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Auro-Cefprozil (Auro Pharma, 500 mg, 125 mg, 250 mg)

ABOUT THIS MEDICATION

AURO-CEFPROZIL is the generic brand name for a drug called cefprozil.

What the medication is used for:

The most common uses of AURO-CEFPROZIL are:

  • respiratory infections
  • urinary tract infections
  • skin infections
  • acute sinusitis
  • bronchitis
  • ears infections

Antibacterial drugs like AURO-CEFPROZIL treat only bacterial infections. They do not treat viral infections such as the common cold. Although you may feel better early in treatment, AURO-CEFPROZIL should be used exactly as directed. Misuse or overuse of AURO-CEFPROZIL could lead to the growth of bacteria that will not be killed by AURO-CEFPROZIL (resistance). This means that AURO-CEFPROZIL may not work for you in the future. Do not share your medicine.

For other possible uses, please speak to your doctor or pharmacist.

What it does:

AURO-CEFPROZIL is an antibiotic which kills the bacteria that cause infections.

When it should not be used:

Do not use if allergic to cefprozil or any of the nonmedicinal ingredients present in AURO-CEFPROZIL (See “What the important non-medicinal ingredients are” section below).

What the medicinal ingredient is:

Cefprozil (as cefprozil monohydrate)

What the nonmedicinal ingredients are:

AURO-CEFPROZIL (Cefprozil Tablets 250 mg and 500 mg): Microcrystalline cellulose, Sodium starch glycolate, Magnesium stearate. Additionally 250 mg strength contains Titanium dioxide, Hypromellose, Polyethylene glycol, Polysorbate 80, FD&C yellow No.6/Sunset yellow FCF aluminium lake, Shellac glaze, Iron oxide black and Ammonium hydroxide and 500 mg strength contains Titanium dioxide, Hypromellose, Polyethylene glycol, Polysorbate 80, Shellac glaze, Iron oxide black and Ammonium hydroxide.

Cefprozil powder for oral suspension 125 mg/5 mL and 250 mg/5 mL contains: Sucrose, Sodium chloride, Citric acid monohydrate, Simethicone emulsion, Polysorbate 80, Aspartame, Glycine, Sodium benzoate, Carboxymethylcellulose sodium, Microcrystalline cellulose and Carboxymethylcellulose sodium, Colloidal silicon dioxide, Modified food starch, FD&C Red No: 3 and artificial bubble gum flavour.

What dosage forms it comes in:

Tablets, 250 mg and 500 mg.

Powder for Oral Suspension, 125 mg/5 mL (when reconstituted), and 250 mg/5 mL (when reconstituted).

WARNINGS AND PRECAUTIONS

Before starting AURO-CEFPROZIL and to get the best possible treatment, be sure to tell your doctor if you:

  • Are allergic to penicillins, cephalopsporins, cefprozil or any other drugs.
  • Do not use if you are pregnant, plan to become pregnant or are breastfeeding.

  • Do not use for children below the age of 6 months.

  • Caution is required when cefprozil is used for the chronically ill or institutionalized elderly.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with AURO-CEFPROZIL include aminoglycoside antibiotics and probenecid.

Before you use AURO-CEFPROZIL talk to your doctor or pharmacist.

PROPER USE OF THIS MEDICATION

Adults (13 years and older)

Usual dose:

Respiratory and Urinary Tract Infections: 500 mg once daily.

Skin Infections: 250 mg every 12 hours or 500 mg once daily.

Acute Sinusitis: 250 mg or 500 mg, every 12 hours.

You must take this medication as told by your doctor. The usual dose depends on your age, weight and the type of infection that you have. The maximum daily dose for infants and children (6 months to 12 years of age) should not exceed the maximum daily dose recommended for adults which is 1 g per day.

It is important that you take all the medecine that your doctor has given you. Even if you start to feel better, all the medicine must be taken to make sure that all the germs have been killed.

AURO-CEFPROZIL may be taken with or without food.

Shake the reconstituted suspension well before use.

Overdose:

If you think you have taken too much AURO-CEFPROZIL, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

Call your doctor or pharmacist right away in case of a missed dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects are diarrhea, nausea, vomiting and abdominal pain.

This is not a complete list of side effects. For any unexpected effects while taking AURO-CEFPROZIL, contact your doctor or pharmacist.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Severe Cutaneous Adverse Reactions (SCAR) (severe skin reactions that may also affect other organs):

  • Skin peeling, scaling, or blistering (with or without pus) which may also affect your eyes, mouth, nose or genitals, itching, severe rash, bumps under the skin, skin pain, skin color changes (redness, yellowing, purplish)
  • Swelling and redness of eyes or face
  • Flu-like feeling, fever, chills, body aches, swollen glands, cough
  • Shortness of breath, chest pain or discomfort
✓

HOW TO STORE IT

AURO-CEFPROZIL Tablets and powder: store at room temperature (15°C – 30°C). Protect from light and excessive humidity. Keep out of reach and sight of children.

AURO-CEFPROZIL (Cefprozil for Oral Suspension): reconstituted suspension: must be stored in the refrigerator (2°C – 8°C) for up to 14 days. Keep container tightly closed. Discard unused portion after 14 days. Keep out of reach and sight of children

Do not use AURO-CEFPROZIL after the expiry date indicated on the package.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about AURO-CEFPROZIL:

  • Talk to your healthcare professional
  • Find the full Product Monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug- products/drug-product-database.html; the manufacturer’s website www.auropharma.ca, or by calling 1-855-648-6681.

Auro Pharma Inc.

3700 Steeles Avenue West, Suite # 402

Woodbridge, Ontario, L4L 8K8,

Canada.

Last Revised: February 22, 2023.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02347253

Revision date stated in the text: February 22, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Auro-Cefprozil (Auro Pharma, 500 mg, 125 mg, 250 mg)

Rx or OTC
Prescription (Rx)?
DIN 02347253, 02347261, 02347288
Schedule(s) PRESCRIPTION
Active ingredient(s) Cefprozil
Dosage form(s) Tablet, Powder For Suspension
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DC Second-generation cephalosporins
          1. J01DC10 Cefprozil
Company AURO PHARMA INC
Current status Marketed
Strengths and forms
DIN Strength Dosage form(s) Current status
02347253 500 MG Tablet Marketed January 23, 2019
02347261 125 MG Powder For Suspension Marketed March 1, 2024
02347288 250 MG Powder For Suspension Marketed March 1, 2024

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.